GENE ONLINE|News &
Opinion
Blog

2024-02-21| R&D

USC-Led Study Reveals Benefits of Fasting-Mimicking Diet in Reducing Disease Risk and Slowing Aging

by Richard Chau
Share To

A recent study led by researchers at the University of Southern California (USC) Leonard Davis School of Gerontology suggests that cycles of a fasting-mimicking diet (FMD) can significantly lower risk factors for disease and reduce biological age in humans. Published in Nature Communications on February 20, the study adds to the growing body of evidence supporting the beneficial effects of FMD in combating aging-related health issues.

“This study shows for the first time evidence for biological age reduction from two different clinical trials, accompanied by evidence of rejuvenation of metabolic and immune function,” said Dr. Valter Longo, USC’s Professor in Gerontology and Biological Science and the senior author of the new study.

Related article: Intermittent Fasting Improves Alzheimer’s Pathology, Possibly Breaks New Ground for Future Research

Fasting-Mimicking Diet as a Promising Intervention

The FMD is a 5-day diet high in unsaturated fats and low in overall calories, protein, and carbohydrates, mimicking the effects of water-only fasting while providing necessary nutrients. Developed by Prof. Longo’s laboratory, the diet is more manageable and easier to complete, thereby offering a feasible alternative for individuals seeking the benefits of fasting without stringent lifestyle changes. 

Previous research led by Longo has linked brief and periodic FMD cycles with stem cell regeneration, reduced chemotherapy side effects, and decreased signs of dementia in mice, as well as lower risk factors for various age-related diseases in humans. Besides, the Longo lab previously demonstrated that one or two cycles of FMD for five days a month could protect normal cells while killing damaged cells, reduce inflammation, promote multi-system regeneration, and extend longevity. However, until now, whether FMD has any effect on aging, biological age, liver fat, and immunity in humans has remained an unanswered question.

Evidence of Improved Health and Rejuvenated Cellular and Tissue Functions

Analyzing data from two clinical trial populations involving men and women aged 18 to 70, researchers observed significant improvements in participants following the FMD regimen. Blood test results showed that patients adhering to 3 to 4 monthly cycles of the FMD (one 5-day FMD cycle followed by a 25-day normal diet each month) experienced lower diabetes risk factors, including reduced insulin resistance and glycated hemoglobin (HbA1c) levels. Magnetic resonance imaging revealed a decrease in abdominal and liver fat, indicating a diminished risk of metabolic syndrome. 

Moreover, FMD cycles appeared to rejuvenate the immune system, indicated by an increase in the lymphoid-to-myeloid ratio. Statistical analysis across both trials revealed an average reduction in biological age by 2.5 years among FMD participants, showcasing evidence of cellular and tissue function improvement.

Implications for Healthcare Professionals and the General Population

Lead authors Sebastian Brandhorst and Morgan E. Levine emphasize the study’s implications for health and longevity. The findings suggest that FMD cycles could serve as a short-term, achievable dietary intervention to mitigate disease risks and improve overall well-being without necessitating drastic lifestyle changes. 

With these compelling results, Professor Valter Longo urges healthcare professionals to consider recommending FMD cycles to patients with elevated disease risk factors, as well as to the broader population seeking enhanced functionality and a younger biological age.

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
R&D
Scientists Unlocked the Secret of Genetic Impact of Time-restricted Eating in Mice
2023-01-07
R&D
A longevity chronicle: The development of anti-aging pill
2018-08-14
LATEST
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top